Across TCGA pan-cancer cohorts, GSTA6P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of GSTA6P’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where GSTA6P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GSTA6P is over-expressed in tumor, although a few such as CHOL show the opposite, repressed pattern.

LIHC, LUSC, and CHOL are the cancer types where GSTA6P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GSTA6P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.164	<.001	6	view →
LUSC	All	II,III,IV	+0.127	.026	4	view →
CHOL	Male	All	−0.158	.005	2	view →
KIRC	All	All	+0.018	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: GSTA6P RNA expression & survival · all GSTA6P data types